vs
利氏兄弟拍卖行（RBA）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
利氏兄弟拍卖行的季度营收约是Royalty Pharma plc的1.9倍（$1.2B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 9.1%，领先25.3%），利氏兄弟拍卖行同比增速更快（5.4% vs 4.8%），过去两年利氏兄弟拍卖行的营收复合增速更高（6.3% vs 4.6%）
利氏兄弟拍卖行（股票代码RBA）是全球知名的工业资产拍卖服务商，注册地位于加拿大，属公开上市企业，总部设在美国伊利诺伊州韦斯特切斯特，普通股同时在多伦多证券交易所与纽约证券交易所挂牌交易。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
RBA vs RPRX — 直观对比
营收规模更大
RBA
是对方的1.9倍
$622.0M
营收增速更快
RBA
高出0.6%
4.8%
净利率更高
RPRX
高出25.3%
9.1%
两年增速更快
RBA
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | $109.7M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 14.7% | 62.4% |
| 净利率 | 9.1% | 34.4% |
| 营收同比 | 5.4% | 4.8% |
| 净利润同比 | -7.4% | 2.9% |
| 每股收益（稀释后） | $0.53 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RBARPRX
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $1.1B | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $981.8M | $564.7M | ||
| Q2 24 | $1.1B | $537.3M | ||
| Q1 24 | $1.1B | $568.0M |
净利润RBARPRX
| Q4 25 | $109.7M | $214.2M | ||
| Q3 25 | $95.5M | $288.2M | ||
| Q2 25 | $109.8M | $30.2M | ||
| Q1 25 | $113.4M | $238.3M | ||
| Q4 24 | $118.5M | $208.2M | ||
| Q3 24 | $76.1M | $544.0M | ||
| Q2 24 | $111.1M | $102.0M | ||
| Q1 24 | $107.4M | $4.8M |
营业利润率RBARPRX
| Q4 25 | 14.7% | 62.4% | ||
| Q3 25 | 14.5% | 70.1% | ||
| Q2 25 | 15.9% | 36.3% | ||
| Q1 25 | 17.1% | 94.0% | ||
| Q4 24 | 18.1% | 60.9% | ||
| Q3 24 | 15.6% | — | ||
| Q2 24 | 18.4% | 50.2% | ||
| Q1 24 | 18.7% | -13.0% |
净利率RBARPRX
| Q4 25 | 9.1% | 34.4% | ||
| Q3 25 | 8.7% | 47.3% | ||
| Q2 25 | 9.3% | 5.2% | ||
| Q1 25 | 10.2% | 41.9% | ||
| Q4 24 | 10.4% | 35.1% | ||
| Q3 24 | 7.8% | 96.3% | ||
| Q2 24 | 10.1% | 19.0% | ||
| Q1 24 | 10.1% | 0.8% |
每股收益（稀释后）RBARPRX
| Q4 25 | $0.53 | $0.49 | ||
| Q3 25 | $0.43 | $0.67 | ||
| Q2 25 | $0.53 | $0.07 | ||
| Q1 25 | $0.55 | $0.55 | ||
| Q4 24 | $0.58 | $0.46 | ||
| Q3 24 | $0.36 | $1.21 | ||
| Q2 24 | $0.54 | $0.23 | ||
| Q1 24 | $0.53 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $531.5M | $618.7M |
| 总债务越低越好 | $2.3B | $9.0B |
| 股东权益账面价值 | $5.6B | $9.7B |
| 总资产 | $12.1B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.42× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资RBARPRX
| Q4 25 | $531.5M | $618.7M | ||
| Q3 25 | $674.7M | $938.9M | ||
| Q2 25 | $710.2M | $631.9M | ||
| Q1 25 | $578.1M | $1.1B | ||
| Q4 24 | $533.9M | $929.0M | ||
| Q3 24 | $650.7M | $950.1M | ||
| Q2 24 | $599.5M | $1.8B | ||
| Q1 24 | $462.8M | $843.0M |
总债务RBARPRX
| Q4 25 | $2.3B | $9.0B | ||
| Q3 25 | $2.6B | $8.9B | ||
| Q2 25 | $2.6B | $8.0B | ||
| Q1 25 | $2.6B | $7.6B | ||
| Q4 24 | $2.6B | $7.6B | ||
| Q3 24 | $2.7B | $7.6B | ||
| Q2 24 | $2.8B | $7.6B | ||
| Q1 24 | $2.9B | $6.1B |
股东权益RBARPRX
| Q4 25 | $5.6B | $9.7B | ||
| Q3 25 | $5.5B | $9.6B | ||
| Q2 25 | $5.5B | $9.5B | ||
| Q1 25 | $5.3B | $9.8B | ||
| Q4 24 | $5.2B | $10.3B | ||
| Q3 24 | $5.2B | $10.3B | ||
| Q2 24 | $5.2B | $9.8B | ||
| Q1 24 | $5.1B | $9.9B |
总资产RBARPRX
| Q4 25 | $12.1B | $19.6B | ||
| Q3 25 | $12.2B | $19.3B | ||
| Q2 25 | $12.2B | $18.3B | ||
| Q1 25 | $11.9B | $17.6B | ||
| Q4 24 | $11.8B | $18.2B | ||
| Q3 24 | $11.9B | $18.0B | ||
| Q2 24 | $12.1B | $17.7B | ||
| Q1 24 | $12.0B | $16.1B |
负债/权益比RBARPRX
| Q4 25 | 0.42× | 0.92× | ||
| Q3 25 | 0.47× | 0.93× | ||
| Q2 25 | 0.47× | 0.84× | ||
| Q1 25 | 0.50× | 0.78× | ||
| Q4 24 | 0.50× | 0.74× | ||
| Q3 24 | 0.52× | 0.74× | ||
| Q2 24 | 0.55× | 0.78× | ||
| Q1 24 | 0.58× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $255.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $186.5M | — |
| 自由现金流率自由现金流/营收 | 15.5% | — |
| 资本支出强度资本支出/营收 | 5.7% | — |
| 现金转化率经营现金流/净利润 | 2.33× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $719.2M | — |
8季度趋势，按日历期对齐
经营现金流RBARPRX
| Q4 25 | $255.2M | $827.1M | ||
| Q3 25 | $239.7M | $702.6M | ||
| Q2 25 | $326.5M | $364.0M | ||
| Q1 25 | $156.8M | $596.1M | ||
| Q4 24 | $184.5M | $742.5M | ||
| Q3 24 | $285.4M | $703.6M | ||
| Q2 24 | $337.3M | $658.2M | ||
| Q1 24 | $124.8M | $664.6M |
自由现金流RBARPRX
| Q4 25 | $186.5M | — | ||
| Q3 25 | $188.5M | — | ||
| Q2 25 | $241.7M | — | ||
| Q1 25 | $102.5M | — | ||
| Q4 24 | $127.9M | — | ||
| Q3 24 | $248.5M | — | ||
| Q2 24 | $308.6M | — | ||
| Q1 24 | $79.6M | — |
自由现金流率RBARPRX
| Q4 25 | 15.5% | — | ||
| Q3 25 | 17.3% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 9.2% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 25.3% | — | ||
| Q2 24 | 28.2% | — | ||
| Q1 24 | 7.5% | — |
资本支出强度RBARPRX
| Q4 25 | 5.7% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 7.2% | — | ||
| Q1 25 | 4.9% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 4.2% | — |
现金转化率RBARPRX
| Q4 25 | 2.33× | 3.86× | ||
| Q3 25 | 2.51× | 2.44× | ||
| Q2 25 | 2.97× | 12.06× | ||
| Q1 25 | 1.38× | 2.50× | ||
| Q4 24 | 1.56× | 3.57× | ||
| Q3 24 | 3.75× | 1.29× | ||
| Q2 24 | 3.04× | 6.45× | ||
| Q1 24 | 1.16× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RBA
| Buyer Revenue | $577.2M | 48% |
| Seller Revenue | $255.2M | 21% |
| CA | $199.0M | 17% |
| Other | $124.7M | 10% |
| AU | $47.3M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
